Jump to content

Jerome Kim

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Citation bot (talk | contribs) at 08:58, 27 March 2023 (Alter: template type. Add: s2cid, bibcode, pmid, pages, issue, volume, doi, year, journal, authors 1-1. Removed parameters. Some additions/deletions were parameter name changes. | Use this bot. Report bugs. | Suggested by Spinixster | Category:Yale School of Medicine alumni | #UCB_Category 216/243). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Jerome Hahn Kim is Director General of the International Vaccine Institute (IVI).[1][2]

He was educated at University of Hawaiʻi at Mānoa where he studied Biology and History, the Yale School of Medicine (MD, 1984), and completed his training at Duke University Medical Center.[3][4] Prior to IVI, Dr. Kim led the US Army's advanced development program for HIV vaccines, the RV 144 HIV vaccine trial, and a molecular virology laboratory at Walter Reed Army Institute of Research.[3]

He has an h-index of 70 according to Google Scholar.[5]

References

  1. ^ Ledford, Heidi (2021). "Why COVID vaccines are so difficult to compare". Nature. 591 (7848): 16–17. Bibcode:2021Natur.591...16L. doi:10.1038/d41586-021-00409-0. PMID 33623151. S2CID 232039872. Retrieved 15 July 2021.
  2. ^ "India's Covid Curve Could Raise the World's". The Wall Street Journal. Retrieved 15 July 2021.
  3. ^ a b "Scientific Advisory Board". Vaccitech. Retrieved 15 July 2021.
  4. ^ "Jerome Kim Named to Head South Korea's International Vaccine Institute". John A. Burns School of Medicine. Retrieved 15 July 2021.
  5. ^ "Jerome Kim". Google Scholar. Retrieved 15 July 2021.
Stub icon

This biographical article related to medicine is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Jerome_Kim&oldid=1146846947"